Greenwich Rx Recalls Compounded Sterile Drugs Over Sterility Concerns
On November 20, 2026, FDA MedWatch Safety Alerts reported that Greenwich Rx is voluntarily recalling specific lots of compounded sterile products across the United States. Greenwich Rx is a 503A compounding pharmacy based in Tomball, Texas. The recall affects medications dispensed nationwide between August 10, 2026, and September 21, 2026, including items made for another pharmacy called Clove Rx. Greenwich Rx initiated the recall due to a potential lack of sterility assurance following an inspection by the U.S. Food and Drug Administration. Using non-sterile drug products intended to be sterile can lead to severe or life-threatening infections. Greenwich Rx stated it has not found direct evidence of contamination in the recalled products and has received no reports of adverse reactions so far. Consumers and clinics holding these medications should immediately stop using them and discard them safely. Customers can contact Sedgwick by phone at 888-243-5547 for assistance with recall questions.
What was announced
Greenwich Rx issued a voluntary recall on November 20, 2026, for specific batches of its compounded sterile drug products. The recall covers products that remain within their beyond-use dates. This action includes medications that Greenwich Rx compounded for Clove Rx.
The company distributed these drugs across the country between August 10, 2026, and September 21, 2026. Greenwich Rx decided to recall the products after an inspection by the U.S. Food and Drug Administration raised concerns about sterility. The pharmacy is reaching out to affected customers by mail.
What it means
A compounded sterile product is a drug prepared in a specialized pharmacy environment to ensure it contains no bacteria or microbes. Non-sterile drugs meant for sterile use pose health risks because they can cause serious or life-threatening infections.
Greenwich Rx stated that it has found no evidence of contamination in any recalled lots. It has also received zero reports of adverse health events related to the products. The pharmacy describes the action as a precaution.
Patients and clinics that hold any recalled drug must stop using it immediately and dispose of it. Customers can cross-reference medication labels with a lot list hosted on the Greenwich Rx website. Questions can go to Sedgwick at 888-243-5547 or GreenwichRx6588@sedgwick.com.
What the announcement does not tell us
The official notice omits several specific details about the issue:
- It does not list individual drug names or lot numbers directly in the text.
- The statement leaves out the specific findings from the FDA inspection.
- The document does not explain how many total units or patients were affected.
- It does not state whether Greenwich Rx will provide refunds or replacement medications.
How this was written
This analysis was written with AI from the official announcement below, using only facts that announcement states. The quoted wording is FDA MedWatch Safety Alerts’s own. Always check the original before acting on anything here.
FOR IMMEDIATE RELEASE - Tomball, Texas – November 20, 2026 – Greenwich Rx, a 503A compounding pharmacy, is voluntarily recalling specific lots of compounded sterile products that remain within their beyond-use dates to the consumer level, including some products that were compounded by Greenwich Rx
Opens www.fda.gov
More from FDA MedWatch Safety Alerts
- Early Alert: Heraeus Medical Components Removes Vascular Guidewires20 November 2026
- Breckenridge Pharmaceutical, Inc. Issues Voluntary Nationwide Consumer-Level Recall of One Lot of Propranolol Hydrochloride Extended-Release Capsules, USP, 60 mg, Due to Potential Metal Contamination20 November 2026
- Early Alert: Outset Medical Updates Use Instructions for the Tablo Console and the TabloCart with Prefiltration Drawer19 November 2026
- Medical Device Correction Update Luna® G3 BPAP System (Model LG3800-30VT)19 November 2026
- Early Alert: B. Braun Medical Inc. Updates Use Instructions for Caresite Micro Luer Access Device19 November 2026
This content is for informational purposes only and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare professional before starting any supplement, treatment, or program: especially if you are pregnant, nursing, taking medication, or managing a health condition.